Cargando…

Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study

AIM: To compare the effects of regular vs low-FODMAP rye bread on irritable bowel syndrome (IBS) symptoms and to study gastrointestinal conditions with SmartPill(®). METHODS: Our aim was to evaluate if rye bread low in FODMAPs would cause reduced hydrogen excretion, lower intraluminal pressure, high...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirkola, Laura, Laatikainen, Reijo, Loponen, Jussi, Hongisto, Sanna-Maria, Hillilä, Markku, Nuora, Anu, Yang, Baoru, Linderborg, Kaisa M, Freese, Riitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859228/
https://www.ncbi.nlm.nih.gov/pubmed/29568206
http://dx.doi.org/10.3748/wjg.v24.i11.1259
_version_ 1783307779508797440
author Pirkola, Laura
Laatikainen, Reijo
Loponen, Jussi
Hongisto, Sanna-Maria
Hillilä, Markku
Nuora, Anu
Yang, Baoru
Linderborg, Kaisa M
Freese, Riitta
author_facet Pirkola, Laura
Laatikainen, Reijo
Loponen, Jussi
Hongisto, Sanna-Maria
Hillilä, Markku
Nuora, Anu
Yang, Baoru
Linderborg, Kaisa M
Freese, Riitta
author_sort Pirkola, Laura
collection PubMed
description AIM: To compare the effects of regular vs low-FODMAP rye bread on irritable bowel syndrome (IBS) symptoms and to study gastrointestinal conditions with SmartPill(®). METHODS: Our aim was to evaluate if rye bread low in FODMAPs would cause reduced hydrogen excretion, lower intraluminal pressure, higher colonic pH, different transit times, and fewer IBS symptoms than regular rye bread. The study was a randomized, double-blind, controlled cross-over meal study. Female IBS patients (n = 7) ate study breads at three consecutive meals during one day. The diet was similar for both study periods except for the FODMAP content of the bread consumed during the study day. Intraluminal pH, transit time, and pressure were measured by SmartPill, an indigestible motility capsule. RESULTS: Hydrogen excretion (a marker of colonic fermentation) expressed as area under the curve (AUC)((0-630 min)) was [median (range)] 6300 (1785-10800) ppm∙min for low-FODMAP rye bread and 10 635 (4215-13080) ppm∙min for regular bread (P = 0.028). Mean scores of gastrointestinal symptoms showed no statistically significant differences but suggested less flatulence after low-FODMAP bread consumption (P = 0.063). Intraluminal pressure correlated significantly with total symptom score after regular rye bread (ρ = 0.786, P = 0.036) and nearly significantly after low-FODMAP bread consumption (ρ = 0.75, P = 0.052). We found no differences in pH, pressure, or transit times between the breads. Gastric residence of SmartPill was slower than expected. SmartPill left the stomach in less than 5 h only during one measurement (out of 14 measurements in total) and therefore did not follow on par with the rye bread bolus. CONCLUSION: Low-FODMAP rye bread reduced colonic fermentation vs regular rye bread. No difference was found in median values of intraluminal conditions of the gastrointestinal tract.
format Online
Article
Text
id pubmed-5859228
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-58592282018-03-22 Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study Pirkola, Laura Laatikainen, Reijo Loponen, Jussi Hongisto, Sanna-Maria Hillilä, Markku Nuora, Anu Yang, Baoru Linderborg, Kaisa M Freese, Riitta World J Gastroenterol Clinical Trials Study AIM: To compare the effects of regular vs low-FODMAP rye bread on irritable bowel syndrome (IBS) symptoms and to study gastrointestinal conditions with SmartPill(®). METHODS: Our aim was to evaluate if rye bread low in FODMAPs would cause reduced hydrogen excretion, lower intraluminal pressure, higher colonic pH, different transit times, and fewer IBS symptoms than regular rye bread. The study was a randomized, double-blind, controlled cross-over meal study. Female IBS patients (n = 7) ate study breads at three consecutive meals during one day. The diet was similar for both study periods except for the FODMAP content of the bread consumed during the study day. Intraluminal pH, transit time, and pressure were measured by SmartPill, an indigestible motility capsule. RESULTS: Hydrogen excretion (a marker of colonic fermentation) expressed as area under the curve (AUC)((0-630 min)) was [median (range)] 6300 (1785-10800) ppm∙min for low-FODMAP rye bread and 10 635 (4215-13080) ppm∙min for regular bread (P = 0.028). Mean scores of gastrointestinal symptoms showed no statistically significant differences but suggested less flatulence after low-FODMAP bread consumption (P = 0.063). Intraluminal pressure correlated significantly with total symptom score after regular rye bread (ρ = 0.786, P = 0.036) and nearly significantly after low-FODMAP bread consumption (ρ = 0.75, P = 0.052). We found no differences in pH, pressure, or transit times between the breads. Gastric residence of SmartPill was slower than expected. SmartPill left the stomach in less than 5 h only during one measurement (out of 14 measurements in total) and therefore did not follow on par with the rye bread bolus. CONCLUSION: Low-FODMAP rye bread reduced colonic fermentation vs regular rye bread. No difference was found in median values of intraluminal conditions of the gastrointestinal tract. Baishideng Publishing Group Inc 2018-03-21 2018-03-21 /pmc/articles/PMC5859228/ /pubmed/29568206 http://dx.doi.org/10.3748/wjg.v24.i11.1259 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Clinical Trials Study
Pirkola, Laura
Laatikainen, Reijo
Loponen, Jussi
Hongisto, Sanna-Maria
Hillilä, Markku
Nuora, Anu
Yang, Baoru
Linderborg, Kaisa M
Freese, Riitta
Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title_full Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title_fullStr Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title_full_unstemmed Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title_short Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
title_sort low-fodmap vs regular rye bread in irritable bowel syndrome: randomized smartpill(®) study
topic Clinical Trials Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859228/
https://www.ncbi.nlm.nih.gov/pubmed/29568206
http://dx.doi.org/10.3748/wjg.v24.i11.1259
work_keys_str_mv AT pirkolalaura lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT laatikainenreijo lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT loponenjussi lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT hongistosannamaria lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT hillilamarkku lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT nuoraanu lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT yangbaoru lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT linderborgkaisam lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy
AT freeseriitta lowfodmapvsregularryebreadinirritablebowelsyndromerandomizedsmartpillstudy